SOURCES SOUGHT
A -- NIDDK Genetics Repository
- Notice Date
- 8/24/2007
- Notice Type
- Sources Sought
- NAICS
- 541710
— Research and Development in the Physical, Engineering, and Life Sciences
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, Nat'l Institute of Diabetes, Digestive, & Kidney Diseases, 2 Democracy Plaza, Suite 700W 6707 Democracy Blvd., MSC 5455, Bethesda, MD, 20892-5455, UNITED STATES
- ZIP Code
- 00000
- Solicitation Number
- NIH-NIDDK-07-05
- Response Due
- 11/20/2007
- Archive Date
- 11/20/2007
- Description
- The National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases is conducting a market survey to help determine the availability and technical capability of qualified small businesses, veteran-owned small businesses, service-disabled veteran-owned small businesses and/or HUBZone small businesses capable of serving the needs mentioned below. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) is seeking an organization or an institution to serve as the NIDDK Genetics Repository. The repository shall allow the continued storage, maintenance, and quality control, and equitable, ethical distribution of DNA and other resources important to the study of diseases under the mandate of the NIDDK. It facilitates sharing of resources, thus encouraging work by a broad group of investigators and, perhaps, increasing the sample size and the resulting power of a study to identify the genetic determinants of a disease. It helps to ensure that research participants will be making a maximal contribution, and decreases duplicative sampling efforts. The objective of this acquisition will be to continue the NIDDK Genetics Repository, in order to accomplish the following in a highly efficient, rapid, and cost-effective manner: ? Receive blood samples from NIDK funded grants and contracts ? Process these data and materials to create cell lines, cryopreserved lymphocytes, and/or DNA or RNA samples ? Receive externally produced immortalized lymphocyte cell lines; and ? Widely distribute all materials to qualified investigators in the scientific community in variety of customized formats The cell immortalization and other tasks outlined in this statement of work are highly technical, and require extensive experience and expertise. The success rate for cell immortalization is extremely variable. It depends, in large measure, on how well the established methods are implemented. As the entire value of many genetics studies rests on the ability to analyze the DNA of sib-pairs and other relatives, inability to recover DNA from any particular sample may negate the value of multiple samples. Therefore, it is essential that the success rate for establishing cell lines be as close to 100% as possible. Furthermore, the ability to track thousands of genetic samples, preventing sample mix-ups and cross-contamination while maintaining a high-throughput processing system, is crucial to the integrity of the studies being supported. The Contractor?s project director must have extensive experience in successfully providing these genetics and sample processing services, including blood cell immortalization and DNA extraction and distribution, to a large group of investigators. The Contractor?s staff must be highly trained to carry out exacting technical tasks accurately and reproducibly. As all the work is with samples from human subjects, all staff must be familiar with human subjects protections and be sensitive to the bioethical and safety issues involved in handling human biosamples. Finally, the Contractor must have a demonstrable long-term interest in providing these services, to ensure that there is continuity throughout the period of the contract. Currently all of the required work is in the final year of a NIDDK 5-year funded contract with the Rutgers University Cell & DNA Repository. All qualified small businesses, veteran-owned small businesses, service-disabled veteran-owned small businesses and/or HUBZone small businesses interested in submitting a corporate capability statement should demonstrate experience and knowledge for performing the following tasks: 1) Establish biospecimen preparation, shipping, receipt, and tracking systems for numerous individual multi-center clinical studies; 2) Maintain the confidentiality of subjects by removing all traditional personal identifiers from samples; 3) Establish one or more subcontracts for timely and cost-effective shipping of biosamples between multiple sites and the repository; 4) Create and store viable cell lines via Epstein-Barr virus transformation of lymphocytes from blood samples, with a success rate of 97% or greater and expanding the lymphoblastoid cell lines; 5) Receive and store lymphoblastoid cell lines prepared at other facilities and carry out quality control assessments; 6) Cryopreserve blood cells for eventual transformation and/or DNA extraction; 7) Extract and store DNA from cell lines or from isolated blood cells and, with designated samples, separating the white blood cells (buffy coat) from the plasma; 8) Receive externally produced DNA; 9) Carry out whole genome amplification, pedigree analyses and RNA extraction; 10) Distribute cell lines and biosamples to investigators granted access by the PO, including arraying in a variety of formats, packaging, handling, and coordinating sample shipments to domestic and international sites; 11) Withdraw and destroy samples from the repository as directed in writing by the Project Officer; 12) Establish and maintain Quality Assurance (QA) and Quality Control (QC) programs; 13) Provide security and back-up systems and a plan for disaster recovery; 14) Maintain high quality, secure information systems to allow detailed tracking and reporting of sample receipt, processing, storage and distribution, rapid retrieval of samples, storage of QA/QC information associated with the sample, seamless interaction with the Database Repository, and listing of investigators using the repository; and 15) Work in a cooperative fashion with the Project Officer, the External Advisory Committee, and the Steering Committee. Special Instructions: If you or your firm/business has an interest and possess the required expertise we invite you to submit a corporate capability statement to assist the Government in determining in accordance with Federal Acquisition Regulation (FAR) 19.502-2(b) whether or not this procurement will be set-aside for any of the programs described above. The intended procurement will be classified under North American Industrial Classification (NAICS) code 541710 with a size standard of 500 employees. All respondents are requested to identify their firm's size and type of business. Interested firms responding to this sources sought should adhere to the following: (a) Provide a capability statement demonstrating relevant experience, skills and ability to fulfill the Government's requirements for the above. The capability statement should contain sufficient detail for the Government to make an informed decision regarding your capabilities. The capability statement should not exceed 25 pages and five (5) copies should be submitted. (b) The capability statement should include references, key personnel, and any teaming arrangements needed to fulfill the requirements. (c) All capability statements must be submitted in writing to the address identified in this synopsis no later than July 10, 2007 no later than 3:00pm eastern standard time. Responses will not be accepted via email or fax. This notice is for information and planning purposes only and is not to be construed as a commitment by the Government, nor will the Government pay for information solicited.
- Place of Performance
- Address: Bethesda, MD
- Zip Code: 20817
- Country: UNITED STATES
- Zip Code: 20817
- Record
- SN01384030-W 20070826/070824220646 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |